Survival Fraction at 2 GY
The Survival Fraction at 2 Gy (SF2) is a critical parameter in radiobiology and oncology. It is used to evaluate the sensitivity of cancer cells to radiation therapy. This measure quantifies the proportion of cells that survive after exposure to a 2 Gray (Gy) dose of ionizing radiation, a common dose per fraction used in many radiation therapy treatment plans. The SF2 is significant because it provides insights into the intrinsic radiosensitivity of tumor cells, which can vary widely among different types of cancer and even among tumors of the same type. A lower SF2 value indicates a higher radiosensitivity, meaning that the tumor cells are more likely to be destroyed by radiation. Conversely, a higher SF2 suggests a more radioresistant tumor, potentially requiring higher doses for effective treatment. Assessing the Survival Fraction at 2 Gy (SF2) of tumors can help in tailoring radiation therapy regimens to individual patients, optimizing therapeutic efficacy while minimizing damage to surrounding healthy tissues.
Survival Fraction at 2 GY
Latest Posts
-
RadioGx Computational Platform to Predict Radiation Response Genetic Markers
This study introduces a groundbreaking approach to personalized Radiotherapy by using genetic markers to predict tumor responses, aiming to optimize treatment plans. By analyzing radiogenomic datasets, researchers found genetic signatures that indicate radiation sensitivity, offering a path…

You must be logged in to post a comment.